Options
Investigating the Influential Factors of Mild Water-Filtered Infrared-A Whole-Body Hyperthermia for Pain Relief in Fibromyalgia : A Mixed-Methods Approach Focusing on Predictors and Patient Perspectives
Öznur, Özlem; Schlee, Christoph; Utz, Sandra; u. a. (2024): Investigating the Influential Factors of Mild Water-Filtered Infrared-A Whole-Body Hyperthermia for Pain Relief in Fibromyalgia : A Mixed-Methods Approach Focusing on Predictors and Patient Perspectives, in: Bamberg: Otto-Friedrich-Universität, S. 1–12.
Author:
Publisher Information:
Year of publication:
2024
Pages:
Source/Other editions:
Biomedicines : open access journal, 11 (2023), 11, 2949, S. 1-12. - ISSN: 2227-9059
Year of first publication:
2023
Language:
English
Abstract:
Fibromyalgia syndrome (FMS) is a chronic condition characterized by chronic widespread pain, persistent fatigue, and disrupted sleep, significantly impacting well-being. Mild water-filtered infrared-A (wIRA) whole-body hyperthermia (WBH) is emerging as a promising pain management approach to FMS. Within the present randomized controlled trial (ClinicalTrials ID: NCT05135936), FMS patients underwent six sessions of mild wIRA-WBH over 3 weeks. Their pain levels were assessed at baseline and at week 12, while body core temperature and plateau phase duration were monitored during WBH. Qualitative interviews were conducted at week 12. Results from this mixed-methods study revealed that baseline pain intensity and plateau phase duration significantly predicted pain intensity at week 12. Thematic analysis of the interviews revealed diverse patient experiences with the treatment, with all patients reporting improvements in perceived pain and overall well-being. The onset and duration of pain relief varied among individuals. Overall, the findings suggest that the duration of the plateau phase may serve as an indicator for long-term pain reduction, although individual factors may influence treatment outcomes. Despite varying experiences, a prevailing trend of positive patient evaluations emerged. This study sheds light on the potential of wIRA-WBH as a therapeutic option for alleviating pain for and enhancing the well-being of FMS patients.
GND Keywords: ; ;
Fibromyalgie
Ganzkörper-Hyperthermie
Schmerzlinderung
Keywords: ; ; ; ;
fibromyalgia
whole-body hyperthermia
randomized controlled trial
integrative medicine
mixed methods
DDC Classification:
RVK Classification:
Peer Reviewed:
Yes:
International Distribution:
Yes:
Open Access Journal:
Yes:
Type:
Article
Activation date:
April 12, 2024
Permalink
https://fis.uni-bamberg.de/handle/uniba/94680